{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T05:30:46Z","timestamp":1776922246093,"version":"3.51.2"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Comput Aided Mol Des"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1007\/s10822-019-00226-8","type":"journal-article","created":{"date-parts":[[2019,10,19]],"date-time":"2019-10-19T18:25:41Z","timestamp":1571509541000},"page":"799-815","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Discovery of a nanomolar inhibitor of the human glyoxalase-I enzyme using structure-based poly-pharmacophore modelling and molecular docking"],"prefix":"10.1007","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1599-5704","authenticated-orcid":false,"given":"Nizar A.","family":"Al-Shar\u2019i","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qosay A.","family":"Al-Balas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rand A.","family":"Al-Waqfi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad A.","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amer E.","family":"Alkhalifa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nehad M.","family":"Ayoub","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,10,19]]},"reference":[{"issue":"2","key":"226_CR1","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0021-9258(18)88610-0","volume":"14","author":"HD Dakin","year":"1913","unstructured":"Dakin HD, Dudley HW (1913) An enzyme concerned with the formation of hydroxy acids from ketonic aldehydes. J Biol Chem 14(2):155\u2013157","journal-title":"J Biol Chem"},{"issue":"4","key":"226_CR2","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/0306-3623(95)02054-3","volume":"27","author":"PJ Thornalley","year":"1996","unstructured":"Thornalley PJ (1996) Pharmacology of methylglyoxal: formation, modification of proteins and nucleic acids, and enzymatic detoxification-A role in pathogenesis and antiproliferative chemotherapy. Gen Pharmacol: Vasc Syst 27(4):565\u2013573. https:\/\/doi.org\/10.1016\/0306-3623(95)02054-3","journal-title":"Gen Pharmacol: Vasc Syst"},{"issue":"6","key":"226_CR3","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1085\/jgp.8.6.519","volume":"8","author":"O Warburg","year":"1927","unstructured":"Warburg O, Wind F, Negelein E (1927) The metabolism of tumors in the body. J Gen Physiol 8(6):519\u2013530","journal-title":"J Gen Physiol"},{"issue":"2","key":"226_CR4","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jtbi.2007.05.019","volume":"248","author":"Y-L Chen","year":"2007","unstructured":"Chen Y-L, Li Q-Z (2007) Prediction of apoptosis protein subcellular location using improved hybrid approach and pseudo-amino acid composition. J Theor Biol 248(2):377\u2013381. https:\/\/doi.org\/10.1016\/j.jtbi.2007.05.019","journal-title":"J Theor Biol"},{"issue":"1","key":"226_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1042\/bj20121743","volume":"453","author":"M Sousa Silva","year":"2013","unstructured":"Sousa Silva M, Gomes Ricardo A, Ferreira Antonio EN, Ponces Freire A, Cordeiro C (2013) The glyoxalase pathway: the first hundred years\u2026 and beyond. Biochem J 453(1):1\u201315. https:\/\/doi.org\/10.1042\/bj20121743","journal-title":"Biochem J"},{"issue":"2","key":"226_CR6","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1080\/15384047.2015.1121346","volume":"17","author":"Y Guo","year":"2016","unstructured":"Guo Y, Zhang Y, Yang X, Lu P, Yan X, Xiao F, Zhou H, Wen C, Shi M, Lu J, Meng QH (2016) Effects of methylglyoxal and glyoxalase I inhibition on breast cancer cells proliferation, invasion, and apoptosis through modulation of MAPKs, MMP9, and Bcl-2. Cancer Biol Ther 17(2):169\u2013180. https:\/\/doi.org\/10.1080\/15384047.2015.1121346","journal-title":"Cancer Biol Ther"},{"issue":"6","key":"226_CR7","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1042\/bst0311372","volume":"31","author":"PJ Thornalley","year":"2003","unstructured":"Thornalley PJ (2003) Protecting the genome: defence against nucleotide glycation and emerging role of glyoxalase I overexpression in multidrug resistance in cancer chemotherapy. Biochem Soc Trans 31(6):1372. https:\/\/doi.org\/10.1042\/bst0311372","journal-title":"Biochem Soc Trans"},{"issue":"1","key":"226_CR8","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1023\/A:1010632919129","volume":"66","author":"A Rulli","year":"2001","unstructured":"Rulli A, Carli L, Romani R, Baroni T, Giovannini E, Rosi G, Talesa V (2001) Expression of glyoxalase I and II in normal and breast cancer tissues. Breast Cancer Res Treat 66(1):67\u201372. https:\/\/doi.org\/10.1023\/A:1010632919129","journal-title":"Breast Cancer Res Treat"},{"issue":"14","key":"226_CR9","doi-asserted-by":"publisher","first-page":"1946","DOI":"10.1016\/S0959-8049(02)00236-8","volume":"38","author":"E Mearini","year":"2002","unstructured":"Mearini E, Romani R, Mearini L, Antognelli C, Zucchi A, Baroni T, Porena M, Talesa V (2002) Differing expression of enzymes of the glyoxalase system in superficial and invasive bladder carcinomas. Eur J Cancer 38(14):1946\u20131950. https:\/\/doi.org\/10.1016\/S0959-8049(02)00236-8","journal-title":"Eur J Cancer"},{"issue":"8","key":"226_CR10","first-page":"2513","volume":"7","author":"H Sakamoto","year":"2001","unstructured":"Sakamoto H, Mashima T, Sato S, Hashimoto Y, Yamori T, Tsuruo T (2001) Selective activation of apoptosis program by Sp-bromobenzylglutathione cyclopentyl diester in glyoxalase I-overexpressing human lung cancer cells. Clin Cancer Res 7(8):2513\u20132518","journal-title":"Clin Cancer Res"},{"issue":"10","key":"226_CR11","doi-asserted-by":"publisher","first-page":"3214","DOI":"10.1182\/blood.V95.10.3214","volume":"95","author":"H Sakamoto","year":"2000","unstructured":"Sakamoto H, Mashima T, Kizaki A, Dan S, Hashimoto Y, Naito M, Tsuruo T (2000) Glyoxalase I is involved in resistance of human leukemia cells to antitumor agent-induced apoptosis. Blood 95(10):3214\u20133218","journal-title":"Blood"},{"issue":"3","key":"226_CR12","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.semcdb.2011.02.006","volume":"22","author":"PJ Thornalley","year":"2011","unstructured":"Thornalley PJ, Rabbani N (2011) Glyoxalase in tumourigenesis and multidrug resistance. Semin Cell Dev Biol 22(3):318\u2013325. https:\/\/doi.org\/10.1016\/j.semcdb.2011.02.006","journal-title":"Semin Cell Dev Biol"},{"issue":"1","key":"226_CR13","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1186\/s12885-017-3367-5","volume":"17","author":"N Kreycy","year":"2017","unstructured":"Kreycy N, Gotzian C, Fleming T, Flechtenmacher C, Grabe N, Plinkert P, Hess J, Zaoui K (2017) Glyoxalase 1 expression is associated with an unfavorable prognosis of oropharyngeal squamous cell carcinoma. BMC Cancer 17(1):382. https:\/\/doi.org\/10.1186\/s12885-017-3367-5","journal-title":"BMC Cancer"},{"issue":"11","key":"226_CR14","first-page":"10852","volume":"10","author":"JC Hai-Tao Peng","year":"2017","unstructured":"Hai-Tao Peng JC, Liu Tian-Yu, Yan-Qing Wu, Lin Xiao-Hong, Lai Yuan-Hui, Huang Ying-Feng (2017) Up-regulation of the tumor promoter glyoxalase-1 indicates poor prognosis in breast cancer. Int J Clin Exp Pathol 10(11):10852\u201310862","journal-title":"Int J Clin Exp Pathol"},{"issue":"5","key":"226_CR15","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/0006-291X(69)90445-8","volume":"35","author":"R Vince","year":"1969","unstructured":"Vince R, Wadd WB (1969) Glyoxalase inhibitors as potential anticancer agents. Biochem Biophys Res Commun 35(5):593\u2013598. https:\/\/doi.org\/10.1016\/0006-291X(69)90445-8","journal-title":"Biochem Biophys Res Commun"},{"issue":"14","key":"226_CR16","doi-asserted-by":"publisher","first-page":"2161","DOI":"10.1021\/jm00040a007","volume":"37","author":"NSRK Murthy","year":"1994","unstructured":"Murthy NSRK, Bakeris T, Kavarana MJ, Hamilton DS, Lan Y, Creighton DJ (1994) S-(N-Aryl-N-hydroxycarbamoyl)glutathione derivatives are tight-binding inhibitors of glyoxalase I and slow substrates for glyoxalase II. J Med Chem 37(14):2161\u20132166. https:\/\/doi.org\/10.1021\/jm00040a007","journal-title":"J Med Chem"},{"issue":"15","key":"226_CR17","doi-asserted-by":"publisher","first-page":"4650","DOI":"10.1021\/jm900382u","volume":"52","author":"SS More","year":"2009","unstructured":"More SS, Vince R (2009) Inhibition of glyoxalase I: the first low-nanomolar tight-binding inhibitors. J Med Chem 52(15):4650\u20134656. https:\/\/doi.org\/10.1021\/jm900382u","journal-title":"J Med Chem"},{"issue":"5","key":"226_CR18","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1021\/jm00287a006","volume":"14","author":"R Vince","year":"1971","unstructured":"Vince R, Daluge S, Wadd WB (1971) Inhibition of glyoxalase I by S-substituted glutathiones. J Med Chem 14(5):402\u2013404. https:\/\/doi.org\/10.1021\/jm00287a006","journal-title":"J Med Chem"},{"issue":"7","key":"226_CR19","doi-asserted-by":"publisher","first-page":"3969","DOI":"10.1016\/j.bmc.2008.01.031","volume":"16","author":"R Takasawa","year":"2008","unstructured":"Takasawa R, Takahashi S, Saeki K, Sunaga S, Yoshimori A, Tanuma S-i (2008) Structure-activity relationship of human GLO I inhibitory natural flavonoids and their growth inhibitory effects. Bioorg Med Chem 16(7):3969\u20133975. https:\/\/doi.org\/10.1016\/j.bmc.2008.01.031","journal-title":"Bioorg Med Chem"},{"issue":"1","key":"226_CR20","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.bpc.2009.12.007","volume":"147","author":"M Liu","year":"2010","unstructured":"Liu M, Yuan M, Luo M, Bu X, Luo H-B, Hu X (2010) Binding of curcumin with glyoxalase I: molecular docking, molecular dynamics simulations, and kinetics analysis. Biophys Chem 147(1):28\u201334. https:\/\/doi.org\/10.1016\/j.bpc.2009.12.007","journal-title":"Biophys Chem"},{"issue":"24","key":"226_CR21","doi-asserted-by":"publisher","first-page":"7486","DOI":"10.1016\/j.bmcl.2012.10.045","volume":"22","author":"T Chiba","year":"2012","unstructured":"Chiba T, Ohwada J, Sakamoto H, Kobayashi T, Fukami TA, Irie M, Miura T, Ohara K, Koyano H (2012) Design and evaluation of azaindole-substituted N-hydroxypyridones as glyoxalase I inhibitors. Bioorg Med Chem Lett 22(24):7486\u20137489. https:\/\/doi.org\/10.1016\/j.bmcl.2012.10.045","journal-title":"Bioorg Med Chem Lett"},{"issue":"3","key":"226_CR22","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1021\/acs.jmedchem.8b01868","volume":"62","author":"C Perez","year":"2019","unstructured":"Perez C, Barkley-Levenson AM, Dick BL, Glatt PF, Martinez Y, Siegel D, Momper JD, Palmer AA, Cohen SM (2019) Metal-binding pharmacophore library yields the discovery of a glyoxalase 1 inhibitor. J Med Chem 62(3):1609\u20131625. https:\/\/doi.org\/10.1021\/acs.jmedchem.8b01868","journal-title":"J Med Chem"},{"issue":"14","key":"226_CR23","doi-asserted-by":"publisher","first-page":"4337","DOI":"10.1016\/j.bmcl.2011.05.046","volume":"21","author":"R Takasawa","year":"2011","unstructured":"Takasawa R, Tao A, Saeki K, Shionozaki N, Tanaka R, Uchiro H, Takahashi S, Yoshimori A, Tanuma S-i (2011) Discovery of a new type inhibitor of human glyoxalase I by myricetin-based 4-point pharmacophore. Bioorg Med Chem Lett 21(14):4337\u20134342. https:\/\/doi.org\/10.1016\/j.bmcl.2011.05.046","journal-title":"Bioorg Med Chem Lett"},{"issue":"12","key":"226_CR24","doi-asserted-by":"publisher","first-page":"13740","DOI":"10.3390\/molecules171213740","volume":"17","author":"Q Al-Balas","year":"2012","unstructured":"Al-Balas Q, Hassan M, Al-Oudat B, Alzoubi H, Mhaidat N, Almaaytah A (2012) Generation of the first structure-based pharmacophore model containing a selective \u201czinc binding group\u201d feature to identify potential glyoxalase-1 inhibitors. Molecules 17(12):13740\u201313758. https:\/\/doi.org\/10.3390\/molecules171213740","journal-title":"Molecules"},{"key":"226_CR25","doi-asserted-by":"publisher","first-page":"2623","DOI":"10.2147\/DDDT.S110997","volume":"10","author":"QA Al-Balas","year":"2016","unstructured":"Al-Balas QA, Hassan MA, Al-Shar\u2019i NA, Mhaidat NM, Almaaytah AM, Al-Mahasneh FM, Isawi IH (2016) Novel glyoxalase-i inhibitors possessing a \u201czinc-binding feature\u201d as potential anticancer agents. Drug design, development and therapy 10:2623. https:\/\/doi.org\/10.2147\/DDDT.S110997","journal-title":"Drug design, development and therapy"},{"issue":"4","key":"226_CR26","doi-asserted-by":"publisher","first-page":"281","DOI":"10.2174\/1389557518666181009141231","volume":"19","author":"QA Al-Balas","year":"2019","unstructured":"Al-Balas QA, Hassan MA, Al-Shar'i NA, Al Jabal GA, Almaaytah AM (2019) Recent advances in glyoxalase-I inhibition. Mini-Rev Med Chem 19(4):281\u2013291. https:\/\/doi.org\/10.2174\/1389557518666181009141231","journal-title":"Chemistry"},{"issue":"12","key":"226_CR27","doi-asserted-by":"publisher","first-page":"3386","DOI":"10.1093\/emboj\/16.12.3386","volume":"16","author":"AD Cameron","year":"1997","unstructured":"Cameron AD, Olin B, Ridderstr\u00f6m M, Mannervik B, Jones TA (1997) Crystal structure of human glyoxalase I-evidence for gene duplication and 3D domain swapping. EMBO J 16(12):3386\u20133395. https:\/\/doi.org\/10.1093\/emboj\/16.12.3386","journal-title":"EMBO J"},{"issue":"41","key":"226_CR28","doi-asserted-by":"publisher","first-page":"13480","DOI":"10.1021\/bi990696c","volume":"38","author":"AD Cameron","year":"1999","unstructured":"Cameron AD, Ridderstr\u00f6m M, Olin B, Kavarana MJ, Creighton DJ, Mannervik B (1999) Reaction mechanism of glyoxalase I explored by an X-ray crystallographic analysis of the human enzyme in complex with a transition state analogue. Biochemistry 38(41):13480\u201313490. https:\/\/doi.org\/10.1021\/bi990696c","journal-title":"Biochemistry"},{"key":"226_CR29","volume-title":"Discovery studio modeling environment, Pipeline Pilot Client","author":"DS Biovia","year":"2017","unstructured":"Biovia DS (2017) Discovery studio modeling environment, Pipeline Pilot Client. Dassault Syst\u00e8mes, San Diego"},{"key":"226_CR30","volume-title":"The PyMOL molecular graphics system","author":"WL DeLano","year":"2002","unstructured":"DeLano WL (2002) The PyMOL molecular graphics system. DeLano Scientific, San Carlos, CA"},{"key":"226_CR31","unstructured":"GraphPad Prism (2012). 6.01 for Windows edn., La Jolla California USA"},{"issue":"1","key":"226_CR32","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1107\/S0907444902003451","volume":"58","author":"HM Berman","year":"2002","unstructured":"Berman HM, Battistuz T, Bhat TN, Bluhm WF, Bourne PE, Burkhardt K, Feng Z, Gilliland GL, Iype L, Jain S, Fagan P, Marvin J, Padilla D, Ravichandran V, Schneider B, Thanki N, Weissig H, Westbrook JD, Zardecki C (2002) The protein data bank. Acta Crystallogr D 58(1):899\u2013907. https:\/\/doi.org\/10.1107\/S0907444902003451","journal-title":"Acta Crystallogr D"},{"issue":"1","key":"226_CR33","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1107\/S0108767307035623","volume":"64","author":"H Berman","year":"2008","unstructured":"Berman H (2008) The protein data bank: a historical perspective. Acta Crystallogr A 64(1):88\u201395. https:\/\/doi.org\/10.1107\/S0108767307035623","journal-title":"Acta Crystallogr A"},{"issue":"2","key":"226_CR34","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1093\/protein\/gzm083","volume":"21","author":"VZ Spassov","year":"2008","unstructured":"Spassov VZ, Flook PK, Yan L (2008) LOOPER: a molecular mechanics-based algorithm for protein loop prediction. Protein Eng Des Sel 21(2):91\u2013100. https:\/\/doi.org\/10.1093\/protein\/gzm083","journal-title":"Protein Eng Des Sel"},{"issue":"11","key":"226_CR35","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1110\/ps.036335.108","volume":"17","author":"VZ Spassov","year":"2008","unstructured":"Spassov VZ, Yan L (2008) A fast and accurate computational approach to protein ionization. Protein Sci 17(11):1955\u20131970. https:\/\/doi.org\/10.1110\/ps.036335.108","journal-title":"Protein Sci"},{"issue":"5","key":"226_CR36","first-page":"83","volume":"8","author":"NA Al-Shar\u2019i","year":"2015","unstructured":"Al-Shar\u2019i NA, Hassan M, Al-Balas Q (2015) Identification of possible glyoxalase II inhibitors as anticancer agents by a customized 3D structure-based pharmacophore mode. Jordan J Pharm Sci 8(5):83\u2013103","journal-title":"Jordan J Pharm Sci"},{"issue":"13","key":"226_CR37","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1002\/jcc.10306","volume":"24","author":"G Wu","year":"2003","unstructured":"Wu G, Robertson DH, Brooks CL, Vieth M (2003) Detailed analysis of grid-based molecular docking: a case study of CDOCKER-A CHARMm-based MD docking algorithm. J Comput Chem 24(13):1549\u20131562. https:\/\/doi.org\/10.1002\/jcc.10306","journal-title":"J Comput Chem"},{"key":"226_CR38","volume-title":"Encyclopedia of computational chemistry","author":"T Schlick","year":"2002","unstructured":"Schlick T (2002) Geometry optimization. In: von Ragu\u00e9 Schleyer P, Allinger NL, Clark T et al (eds) Encyclopedia of computational chemistry. Wiley, New York"},{"issue":"20","key":"226_CR39","doi-asserted-by":"publisher","first-page":"5880","DOI":"10.1021\/jm060763i","volume":"49","author":"J Tirado-Rives","year":"2006","unstructured":"Tirado-Rives J, Jorgensen WL (2006) Contribution of conformer focusing to the uncertainty in predicting free energies for protein\u2212ligand binding. J Med Chem 49(20):5880\u20135884. https:\/\/doi.org\/10.1021\/jm060763i","journal-title":"J Med Chem"},{"issue":"5","key":"226_CR40","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1517\/17460441.2015.1032936","volume":"10","author":"S Genheden","year":"2015","unstructured":"Genheden S, Ryde U (2015) The MM\/PBSA and MM\/GBSA methods to estimate ligand-binding affinities. Expert Opin Drug Discov 10(5):449\u2013461. https:\/\/doi.org\/10.1517\/17460441.2015.1032936","journal-title":"Expert Opin Drug Discov"},{"issue":"11","key":"226_CR41","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.2174\/1570180814666170306120954","volume":"14","author":"QA Al-Balas","year":"2017","unstructured":"Al-Balas QA, Hassan MA, Al Jabal GA, Al-Shar\u2019i NA, Almaaytah AM, El-Elimat T (2017) Novel thiazole carboxylic acid derivatives possessing a \u201czinc binding feature\u201d as potential human glyoxalase-I inhibitors. Lett Drug Des Discov 14(11):1324\u20131334. https:\/\/doi.org\/10.2174\/1570180814666170306120954","journal-title":"Lett Drug Des Discov"},{"issue":"2","key":"226_CR42","doi-asserted-by":"publisher","first-page":"670","DOI":"10.3892\/ijo.2012.1478","volume":"41","author":"MA Fonseca-Sanchez","year":"2012","unstructured":"Fonseca-Sanchez MA, Rodriguez Cuevas S, Mendoza-Hernandez G, Bautista-Pina V, Arechaga Ocampo E, Hidalgo Miranda A, Quintanar Jurado V, Marchat LA, Alvarez-Sanchez E, Perez Plasencia C, Lopez-Camarillo C (2012) Breast cancer proteomics reveals a positive correlation between glyoxalase 1 expression and high tumor grade. Int J Oncol 41(2):670\u2013680. https:\/\/doi.org\/10.3892\/ijo.2012.1478","journal-title":"Int J Oncol"},{"issue":"12","key":"226_CR43","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.3390\/ijms17122133","volume":"17","author":"A Hutschenreuther","year":"2016","unstructured":"Hutschenreuther A, Bigl M, Hemdan NY, Debebe T, Gaunitz F, Birkenmeier G (2016) Modulation of GLO1 expression affects malignant properties of cells. Int J Mol Sci 17(12):2133. https:\/\/doi.org\/10.3390\/ijms17122133","journal-title":"Int J Mol Sci"},{"issue":"7","key":"226_CR44","doi-asserted-by":"publisher","first-page":"2165","DOI":"10.1021\/jm101373a","volume":"54","author":"CB Botta","year":"2011","unstructured":"Botta CB, Cabri W, Cini E, De Cesare L, Fattorusso C, Giannini G, Persico M, Petrella A, Rondinelli F, Rodriquez M, Russo A, Taddei M (2011) Oxime amides as a novel zinc binding group in histone deacetylase inhibitors: synthesis, biological activity, and computational evaluation. J Med Chem 54(7):2165\u20132182. https:\/\/doi.org\/10.1021\/jm101373a","journal-title":"J Med Chem"},{"issue":"5","key":"226_CR45","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1002\/cmdc.200700290","volume":"3","author":"A Agrawal","year":"2008","unstructured":"Agrawal A, Romero-Perez D, Jacobsen JA, Villarreal FJ, Cohen SM (2008) Zinc-binding groups modulate selective inhibition of MMPs. ChemMedChem 3(5):812\u2013820. https:\/\/doi.org\/10.1002\/cmdc.200700290","journal-title":"ChemMedChem"},{"issue":"1","key":"226_CR46","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/BF00124387","volume":"6","author":"H Bohm","year":"1992","unstructured":"Bohm H (1992) The computer program LUDI: a new method for the de novo design of enzyme inhibitors. J Comput Aided Mol Des 6(1):61\u201378","journal-title":"J Comput Aided Mol Des"},{"issue":"6","key":"226_CR47","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1007\/bf00126217","volume":"6","author":"H-J B\u00f6hm","year":"1992","unstructured":"B\u00f6hm H-J (1992) LUDI: rule-based automatic design of new substituents for enzyme inhibitor leads. J Comput Aided Mol Des 6(6):593\u2013606. https:\/\/doi.org\/10.1007\/bf00126217","journal-title":"J Comput Aided Mol Des"},{"issue":"3","key":"226_CR48","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/S0959-440X(96)80061-3","volume":"6","author":"T Lengauer","year":"1996","unstructured":"Lengauer T, Rarey M (1996) Computational methods for biomolecular docking. Curr Opin Struct Biol 6(3):402\u2013406. https:\/\/doi.org\/10.1016\/S0959-440X(96)80061-3","journal-title":"Curr Opin Struct Biol"},{"issue":"Suppl 11","key":"226_CR49","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1186\/s12859-016-1169-4","volume":"17","author":"H Li","year":"2016","unstructured":"Li H, Leung K-S, Wong M-H, Ballester PJ (2016) Correcting the impact of docking pose generation error on binding affinity prediction. BMC Bioinform 17(Suppl 11):308\u2013308. https:\/\/doi.org\/10.1186\/s12859-016-1169-4","journal-title":"BMC Bioinform"},{"issue":"1","key":"226_CR50","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1110\/ps.062501507","volume":"16","author":"S-Y Huang","year":"2007","unstructured":"Huang S-Y, Zou X (2007) Efficient molecular docking of NMR structures: application to HIV-1 protease. Protein Sci 16(1):43\u201351. https:\/\/doi.org\/10.1110\/ps.062501507","journal-title":"Protein Sci"},{"issue":"16","key":"226_CR51","doi-asserted-by":"publisher","first-page":"2870","DOI":"10.3390\/molecules24162870","volume":"24","author":"A Musoev","year":"2019","unstructured":"Musoev A, Numonov S, You Z, Gao H (2019) Discovery of novel DPP-IV inhibitors as potential candidates for the treatment of type 2 diabetes mellitus predicted by 3D QSAR pharmacophore models, molecular docking and de novo evolution. Molecules 24(16):2870","journal-title":"Molecules"},{"issue":"17","key":"226_CR52","doi-asserted-by":"publisher","first-page":"6560","DOI":"10.1021\/jm301916b","volume":"56","author":"T Zhu","year":"2013","unstructured":"Zhu T, Cao S, Su P-C, Patel R, Shah D, Chokshi HB, Szukala R, Johnson ME, Hevener KE (2013) Hit identification and optimization in virtual screening: practical recommendations based on a critical literature analysis. J Med Chem 56(17):6560\u20136572. https:\/\/doi.org\/10.1021\/jm301916b","journal-title":"J Med Chem"},{"issue":"1","key":"226_CR53","doi-asserted-by":"publisher","first-page":"14","DOI":"10.2174\/156802610790232305","volume":"10","author":"K Loving","year":"2010","unstructured":"Loving K, Alberts I, Sherman W (2010) Computational approaches for fragment-based and de novo design. Curr Top Med Chem 10(1):14\u201332. https:\/\/doi.org\/10.2174\/156802610790232305","journal-title":"Curr Top Med Chem"},{"issue":"8","key":"226_CR54","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1038\/nrd1467","volume":"3","author":"DC Rees","year":"2004","unstructured":"Rees DC, Congreve M, Murray CW, Carr R (2004) Fragment-based lead discovery. Nat Rev Drug Discov 3(8):660. https:\/\/doi.org\/10.1038\/nrd1467","journal-title":"Nat Rev Drug Discov"}],"container-title":["Journal of Computer-Aided Molecular Design"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10822-019-00226-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10822-019-00226-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10822-019-00226-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,25]],"date-time":"2021-01-25T10:44:58Z","timestamp":1611571498000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10822-019-00226-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":54,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["226"],"URL":"https:\/\/doi.org\/10.1007\/s10822-019-00226-8","relation":{},"ISSN":["0920-654X","1573-4951"],"issn-type":[{"value":"0920-654X","type":"print"},{"value":"1573-4951","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"3 June 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 September 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 October 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}